Old and new risk factors for upper extremity deep venous thrombosis

被引:117
作者
Blom, JW
Doggen, CJM
Osanto, S
Rosendaal, FR
机构
[1] Leiden Univ, Ctr Med, Dept Clin Epidemiol, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Ctr Med, Dept Oncol, NL-2300 RC Leiden, Netherlands
[3] Leiden Univ, Ctr Med, Hemostasis & Thrombosis Res Ctr, Leiden, Netherlands
关键词
risk factors; upper extremity; venous thrombosis;
D O I
10.1111/j.1538-7836.2005.01625.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Well known risk factors for upper extremity deep venous thrombosis are the presence of a central Venous catheter (CVC) and malignancy, but other potential risk factors, such as Surgery, injury and hormone replacement therapy (HRT), have not yet been explored. Methods: We performed a population-based case-control Study including 179 consecutive patients, aged 18-70 years with upper extremity deep venous thrombosis and 2399 control Subjects. Participants reported oil acquired risk factors in I questionnaire and factor V Leiden and prothrombin 20210A Mutation were ascertained. Information on CVC was obtained from discharge letters. Results: Forty-two patients (23%) and one control subject (0.04%) had a CVC (ORadj: 1136, 95% CI: 153-8448, adjusted for age and sex). Cancer patients Without a CVC had all eightfold increased risk of venous thrombosis of the arm (ORcrude: 7.7, 95%, CI: 4.6-13.0). Other evident risk factors were prothrombotic Mutations, Surgery, immobilization of the arm (plaster cast), oral contraceptive use and family history, with odds ratios varying from 2.0 up to 13.1. The risk ill the presence of injury and during puerperium was two fold or more increased, although not significantly. In contrast HRT, unusual exercise travel and obesity did not increase the risk. Hormone users ha an increased risk in the presence of prothrornbotic mutations or Surgery. Obese persons (BMI > 30 kg m(-2)) undergoing surgery had a 23-fold increased risk of arm thrombosis compared with non-obese persons not undergoing Surgery. Conclusion: A CVC is a very strong risk factor for arm thrombosis. Most risk factors For thrombosis in the leg are also risk factors for arm thrombosis.
引用
收藏
页码:2471 / 2478
页数:8
相关论文
共 30 条
[1]   Prevention of central venous line-related thrombosis by continuous infusion of low-dose unfractionated heparin, in patients with haemato-ontological disease -: A randomized controlled trial [J].
Abdelkefi, A ;
Ben Othman, T ;
Kammoun, L ;
Chelli, M ;
Ben Romdhane, N ;
Kriaa, A ;
Ladeb, S ;
Torjman, L ;
Lakhal, A ;
Achour, W ;
Ben Hassen, A ;
Hsaïri, M ;
Ladeb, F ;
Ben Abdeladhim, A .
THROMBOSIS AND HAEMOSTASIS, 2004, 92 (03) :654-661
[2]  
Baarslag Henk J, 2004, Eur J Intern Med, V15, P503, DOI 10.1016/j.ejim.2004.07.012
[3]   VERY LOW-DOSES OF WARFARIN CAN PREVENT THROMBOSIS IN CENTRAL VENOUS CATHETERS - A RANDOMIZED PROSPECTIVE TRIAL [J].
BERN, MM ;
LOKICH, JJ ;
WALLACH, SR ;
BOTHE, A ;
BENOTTI, PN ;
ARKIN, CF ;
GRECO, FA ;
HUBERMAN, M ;
MOORE, C .
ANNALS OF INTERNAL MEDICINE, 1990, 112 (06) :423-428
[4]   Malignancies, prothrombotic mutations, and the risk of venous thrombosis [J].
Blom, JW ;
Doggen, CJM ;
Osanto, S ;
Rosendaal, FR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (06) :715-722
[5]  
Burihan E, 1993, Cardiovasc Surg, V1, P19
[6]  
Couban S, 2002, BLOOD, V100, p703A
[7]   Estrogen plus progestin and risk of venous thrombosis [J].
Cushman, M ;
Kuller, LH ;
Prentice, R ;
Rodabough, RJ ;
Psaty, BM ;
Stafford, RS ;
Sidney, S ;
Rosendaal, FR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (13) :1573-1580
[8]   Hypercoagulable states in primary upper-extremity deep vein thrombosis [J].
Héron, E ;
Lozinguez, O ;
Alhenc-Gelas, M ;
Emmerich, J ;
Fiessinger, JN .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (03) :382-386
[9]  
HILL SL, 1990, SURGERY, V108, P1
[10]  
HORATTAS MC, 1988, SURGERY, V104, P561